Biological Weapons in the Age of AI: Why Experts Fear Disease Could Be Engineered

Control relies on transparency, voluntary reporting, and good faith.
Unlike chemical weapons, biological weapons have no inspection body to verify the global ban.
Mark

Why is this suddenly in the news if biological weapons have been banned since 1975?

Mimi

Because the tools changed. Biotech lets people alter pathogens precisely, and AI can sift huge amounts of data fast. MI5's Ken McCallum warned in October 2026 that this could raise the risk, including from non-state actors.

Luke

Worth noting that's a warning about risk, not a report of an actual AI-built weapon. The source describes a long-term concern.

Mark

And Anthropic's report?

Mimi

It said it blocked numerous attempts to use Claude in possible bioweapons research, including gain-of-function grant applications and avian influenza projects aimed at mammal transmissibility.

Luke

That's the company's own account. We don't know how many attempts, who made them, or whether any were malicious. Anthropic itself said such research can also be medical prevention.

Mark

So the line between legitimate and dangerous work is blurry?

Mimi

That's the dual-use problem. The same lab equipment makes vaccines or weapons research.

Luke

And the treaty can't settle it. 189 countries ratified the convention, but there's no inspection body like the OPCW for chemical weapons. It runs on good faith.

Mark

Is there a way to tell an attack from a natural outbreak?

Mimi

Only after extensive investigation, according to the source.

  • Britain's domestic intelligence chief warned in October 2026 that AI could sharpen biological weapons threats, even from non-state actors.
  • Anthropic reported in September 2026 that it had blocked numerous attempts to use its Claude assistant for possible bioweapons research.
  • Dual-use research, such as enhancing avian influenza transmissibility, can serve both military ends and vaccine development, making it hard to tell safe work from dangerous.
  • The Biological Weapons Convention bans biological arms in 189 countries but has no inspection body comparable to the chemical weapons watchdog, so it depends on transparency and good faith.
  • Experts are now asking whether verification can evolve fast enough as AI and biotechnology blur the line between science and misuse.

Across the long and uneasy history of humanity's efforts to tame its most destructive tools, a new anxiety has taken shape: that the same intelligence and precision now transforming medicine could also lower the barrier to making living things into weapons. In October 2026, Britain's intelligence chief warned that artificial intelligence might raise the danger posed by biological weapons, including in the hands of groups outside the state, and the warning has drawn scientists and security officials into a question humanity has never fully answered. The old international promise against biological arms remains on paper, yet it rests on trust rather than inspection, and the difficulty lies in a truth that cannot be escaped: the knowledge that heals and the knowledge that harms are often one and the same.

In October 2026, Ken McCallum, the head of Britain's domestic intelligence service MI5, warned that artificial intelligence could raise the risk from existing or new biological weapons, including in the hands of non-state actors. The statement moved a threat once confined to thrillers into serious policy discussion among scientists, security services and international bodies.

The concern rests on two developments advancing together. Biotechnology can now analyze and alter pathogens with growing precision, while AI can process vast data at remarkable speed. In September 2026, the American company Anthropic reported blocking numerous attempts to use its assistant Claude for possible biological weapons research, including grant applications for gain-of-function work and projects on avian influenza variants that might spread most easily to mammals. Anthropic noted that such research could serve medical prevention as well as military purposes, which is exactly the ambiguity that makes modern biotechnology so hard to govern.

Biological weapons are not new. Anthrax, plague, smallpox and botulinum toxin have long been feared, and they differ from chemical agents in how they strike: chemical weapons act within minutes, while biological ones cause infections that unfold over days or weeks, sometimes spreading from person to person. The 1975 Biological Weapons Convention bans their development and stockpiling and has 189 member states, yet it lacks the inspection regime that the chemical weapons watchdog enjoys, because states fear exposing sensitive medical and pharmaceutical secrets. The 2001 anthrax letters in the United States, which infected 22 people and killed five, showed how much damage a small act can do. Detection remains difficult, since an attack may look like a natural outbreak. The open question now is whether verification can keep pace as AI and biotechnology make the boundary between science and misuse ever harder to see.

In October 2026, Ken McCallum, the head of Britain's domestic intelligence service MI5, issued a warning that belongs to a category of threat once confined to thrillers: artificial intelligence, he said, could raise the risk posed by existing or new biological weapons, including in the hands of non-state actors. It is the kind of statement that has pushed scientists, security services and international organizations to ask how such a scenario would be managed.

The worry rests on two parallel developments. Advances in biotechnology allow pathogens to be analyzed and altered with growing precision. AI, meanwhile, can process enormous quantities of data at remarkable speed. Experts caution that, over the long term, the two together could be misused to develop biological weapons.

A report from the American AI company Anthropic, published in September 2026, gave the debate a concrete anchor. The company said it had identified and blocked numerous attempts to use its assistant, Claude, in connection with possible biological weapons research. Those attempts included grant applications for so-called gain-of-function research, and projects looking into variants of avian influenza that might be the most transmissible to mammals. Anthropic also stressed that such work, though it could have military uses, can equally serve medical prevention. That ambiguity is among the hardest problems in controlling modern biotechnology.

Biological weapons themselves are old news. Bacteria, viruses, fungi and certain biological toxins can all be weaponized. Plague, smallpox and botulinum toxin are familiar names, and anthrax is among the most notorious, its resistant spores able to survive long periods in the environment and the subject of state weapons programs. The World Health Organization and the UN Office for Disarmament Affairs define a biological weapon as the deliberate release of such substances to harm people, animals or plants. Experts typically break one down into an agent, such as a virus or bacterium, and a delivery mechanism, such as missiles, spraying systems or contaminated food. Alongside nuclear and chemical arms, they count among the ABC weapons and are often classed as weapons of mass destruction.

They differ from chemical weapons in how they act. Agents like sarin or mustard gas injure through toxicity, often within minutes or seconds; examples include chlorine and mustard gas in World War I, and sarin in the Syrian civil war and under Saddam Hussein in Iraq. Biological weapons cause infectious disease, with effects that surface hours, days or weeks later. Some pathogens spread from person to person, which makes the outcome especially hard to predict.

The law is clear on paper. The Biological Weapons Convention came into force in 1975, banning the development, stockpiling, acquisition, retention, production and transfer of biological and toxin weapons. A product of the earlier Geneva Protocol of 1925, which banned their use in warfare, it has been ratified by 189 countries. Israel, Egypt and Syria are among the few that have not signed or have signed without ratifying. Members commit to destroying stocks, production sites and means of delivery.

Enforcement is the weak point. Chemical weapons have the Organization for the Prohibition of Chemical Weapons, which can inspect and oversee the destruction of stockpiles. Nothing comparable exists for biological weapons, because states fear inspections could expose sensitive medical, biotech or pharmaceutical data. Control therefore depends largely on transparency, voluntary reporting and good faith. The limits of a ban alone were shown in the United States in 2001, when letters containing anthrax spores arrived a few weeks after the September 11 attacks. Twenty-two people were infected and five died.

Detection is harder still. Much of the equipment used to make vaccines and medicines could in theory serve military research, the dual-use problem. And an attack can look like a natural outbreak, with deliberate release established only after extensive investigation. History offers grim precedents, from poisoned wells to plague victims' corpses catapulted over besieged walls, though how effective those methods were is disputed. What to watch now is whether verification can evolve as AI and biotechnology make the line between science and misuse harder to draw.

AI could increase the risk from existing or new biological weapons, including from non-state actors.
— Ken McCallum, head of MI5 (paraphrased)
Contattaci Domande frequenti